Esomecan Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Adult dosage

This medication should be swallowed with liquid such as water and should not be chewed or crushed. 1. Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks - If treatment is incomplete, take for an additional 4 weeks - Maintenance therapy to prevent recurrence: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily (even after symptom relief)

Children's dosage

Adolescents 12 years and older. 1. Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks - If treatment is incomplete, take for an additional 4 weeks - Esophagitis

This medication should not be used in patients with a known allergy to any of its components or a history of hypersensitivity. Caution should be taken, especially in those allergic to benzimidazole derivatives, penicillins, or macrolide antibiotics. In addition, patients taking certain heart-related medications or antiviral drugs, those with a history of myocardial infarction, and nursing mothers should avoid using this medication. This medication contains a pigment called Yellow No. 5 (Tartrazine), so those allergic to this component should use it cautiously. Rarely, various side effects such as blood abnormalities, allergic reactions, gastrointestinal disorders, nervous system symptoms, liver function abnormalities, and skin rashes can occur during treatment, and if any symptoms occur, immediate consultation with healthcare providers is necessary. Regular examinations are needed during long-term use, especially if taken for more than one year, due to the possibility of side effects like hypomagnesemia or increased fracture risk. Since this medication suppresses gastric acid secretion, it may promote bacterial growth in the stomach, so if diarrhea persists, healthcare providers should be informed. Additionally, this medication has significant drug interactions; if other medications are being taken, patients must inform their doctors or pharmacists, and concurrent use with certain drugs should be avoided. Safety data during pregnancy is limited, so it should be used only after consulting a physician, and it is recommended to avoid its use while breastfeeding. In case of overdose, as there is no specific antidote, immediate medical treatment should be sought, and it should be kept out of reach of children.

Serious side effects

Urticaria, angioedema, anaphylaxis reaction/shock, hypomagnesemia, mental confusion, dysgeusia, headache, jaundice, hepatitis, liver failure, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), interstitial nephritis, Clostridium difficile-associated diarrhea, severe edema, seizures, visual disturbances, paralysis.

Mild side effects

Headache, dizziness, abnormal sensation, drowsiness, dysgeusia, blurred vision, bronchospasm, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, increased liver enzymes, hepatitis, liver failure, dermatitis, itching, rash, hair loss, photosensitivity, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, allergic reactions, etc.

This medication should be stored in a tightly closed container to prevent exposure to air and moisture, and it is best to maintain a temperature between 1 to 30 degrees Celsius at room temperature for effective preservation.

Appearance

Pale pink film-coated tablet, round

Package unit

28 tablets (14 tablets/PTPX2)